Nova Leap Health Corp.
NVLPF
$0.1803
-$0.0271-13.07%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.81% | -1.60% | -2.58% | -4.15% | -4.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.81% | -1.60% | -2.58% | -4.15% | -4.00% |
| Cost of Revenue | -0.24% | -3.27% | -6.11% | -8.00% | -7.75% |
| Gross Profit | 2.52% | 1.21% | 3.63% | 2.73% | 2.82% |
| SG&A Expenses | 6.00% | 0.19% | -4.73% | -8.15% | -12.09% |
| Depreciation & Amortization | -21.35% | -34.04% | -37.68% | -40.15% | -36.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.14% | -3.20% | -6.85% | -9.39% | -10.47% |
| Operating Income | -9.35% | 87.68% | 636.24% | 292.70% | 179.32% |
| Income Before Tax | 371.41% | 232.65% | 65.90% | 112.46% | 61.81% |
| Income Tax Expenses | 334.89% | 239.25% | 94.84% | 109.16% | 62.08% |
| Earnings from Continuing Operations | 390.52% | 230.70% | 56.79% | 113.95% | 61.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 390.52% | 230.70% | 56.79% | 113.95% | 61.68% |
| EBIT | -9.35% | 87.68% | 636.24% | 292.70% | 179.32% |
| EBITDA | -17.24% | 6.15% | 99.97% | 171.77% | 924.79% |
| EPS Basic | 382.35% | 230.33% | 55.28% | 113.13% | 58.02% |
| Normalized Basic EPS | 114.00% | 2,200.00% | 203.51% | 334.15% | 256.25% |
| EPS Diluted | 319.05% | 220.63% | 54.96% | 104.85% | 50.59% |
| Normalized Diluted EPS | 114.00% | 2,200.00% | 203.51% | 328.57% | 251.52% |
| Average Basic Shares Outstanding | 0.41% | 0.75% | 0.70% | 2.25% | 3.98% |
| Average Diluted Shares Outstanding | 0.49% | 0.83% | 0.77% | 2.06% | 3.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |